industry collaborators depending on specific TTC constructs

Bayer is a global life sciences company with core competencies in healthcare and nutrition. Its pharmaceutical division focuses on specialty medicine, particularly in oncology, cardiovascular health, and ophthalmology, while also expanding into cell and gene therapies. A key pillar of its oncology innovation is the Targeted Thorium Conjugate (TTC) platform, which utilizes the alpha-emitter thorium-227 to deliver high-energy radiation directly to tumor cells. Bayer manages this platform through a combination of internal research and strategic industry collaborations for specific molecular constructs. The company maintains a robust global presence and a diverse pipeline aimed at addressing significant unmet medical needs.